David A. Siegel 10x Genomics, Inc. Transaction History
Two Sigma Advisers, LP
- $43.8 Billion
- Q2 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 221,300 shares of TXG stock, worth $4.45 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
221,300
Previous 22,500
883.56%
Holding current value
$4.45 Million
Previous $844,000
409.95%
% of portfolio
0.01%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding TXG
# of Institutions
284Shares Held
96.2MCall Options Held
162KPut Options Held
107K-
Vanguard Group Inc Valley Forge, PA10.2MShares$205 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl9.31MShares$187 Million1.65% of portfolio
-
Black Rock Inc. New York, NY6.39MShares$129 Million0.0% of portfolio
-
Nikko Asset Management Americas, Inc.6.15MShares$124 Million1.4% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.6.14MShares$124 Million0.09% of portfolio
About 10x Genomics, Inc.
- Ticker TXG
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 95,046,400
- Market Cap $1.91B
- Description
- 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...